ATE173162T1 - Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen - Google Patents

Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen

Info

Publication number
ATE173162T1
ATE173162T1 AT94112012T AT94112012T ATE173162T1 AT E173162 T1 ATE173162 T1 AT E173162T1 AT 94112012 T AT94112012 T AT 94112012T AT 94112012 T AT94112012 T AT 94112012T AT E173162 T1 ATE173162 T1 AT E173162T1
Authority
AT
Austria
Prior art keywords
medicinal
administration
medical device
homeopatical
active substances
Prior art date
Application number
AT94112012T
Other languages
English (en)
Inventor
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Application granted granted Critical
Publication of ATE173162T1 publication Critical patent/ATE173162T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94112012T 1993-09-02 1994-08-02 Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen ATE173162T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Publications (1)

Publication Number Publication Date
ATE173162T1 true ATE173162T1 (de) 1998-11-15

Family

ID=11401933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94112012T ATE173162T1 (de) 1993-09-02 1994-08-02 Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen

Country Status (12)

Country Link
US (1) US5683712A (de)
EP (1) EP0641561B1 (de)
JP (1) JPH07165566A (de)
KR (1) KR950007808A (de)
AT (1) ATE173162T1 (de)
CA (1) CA2129760A1 (de)
DE (1) DE69414502T2 (de)
DK (1) DK0641561T3 (de)
ES (1) ES2125380T3 (de)
GR (1) GR3029308T3 (de)
IT (1) IT1261849B (de)
ZA (1) ZA946698B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
GB2354636A (en) * 1999-09-25 2001-03-28 Ibm Mounting chips on substrates
FR2806910B1 (fr) * 2000-04-03 2003-01-24 Dolisos Lab Procede d'inactivation virale de solutions hydro-alcooliques
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76638C2 (en) * 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76641C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
US20050255139A1 (en) * 2004-05-14 2005-11-17 Hurd Jonathan L Polymeric compositions with embedded pesticidal desiccants
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
PT3144013T (pt) 2005-12-01 2019-02-07 Univ Massachusetts Lowell Nanoemulsões botulínicas
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
US8658391B2 (en) 2006-04-27 2014-02-25 Anterios, Inc. Assessment of the effects of topical administration of chemodenervating pharmaceuticals
CA2654408C (en) * 2006-06-06 2018-05-08 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
AU2007353340A1 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
BRPI0719756A2 (pt) 2006-12-01 2014-01-21 Anterios Inc Nanopartículas de entidades anfifílicas
EP2124907B1 (de) 2007-03-19 2018-05-30 Vita Sciences, Llc Transdermales pflaster und verfahren zur verabreichung von vitamin b12
WO2008151022A2 (en) 2007-05-31 2008-12-11 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US20090047334A1 (en) * 2007-08-13 2009-02-19 Patricia Williams Transdermal patch for extended delivery of calcium
KR102080429B1 (ko) 2008-06-26 2020-02-21 안테리오스, 인코퍼레이티드 경피 운반
EP2593474A2 (de) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Pharmazeutische kombinationszusammensetzung und verfahren zur behandlung von erkrankungen oder leiden im zusammenhang mit neurodegenerativen erkrankungen
CZ2013105A3 (cs) 2010-07-15 2013-05-22 Iliich Epshtein@Oleg Zpusob zvýsení úcinku aktivované potencované formy protilátky
JP2013532181A (ja) 2010-07-15 2013-08-15 イリイチ・エプシテイン オレグ 組み合わせ医薬組成物及び胃腸管の機能的な疾患又は状態を治療する方法
US9597527B2 (en) 2010-07-17 2017-03-21 Merck Patent Gmbh Enhancement of penetration and action
AU2011281247B2 (en) 2010-07-21 2015-07-30 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
WO2012010970A2 (en) 2010-07-21 2012-01-26 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
SG10201804552WA (en) 2011-01-24 2018-07-30 Anterios Inc Nanoparticle compositions, formulations thereof, and uses therefor
US20120328549A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Oil compositions
TR201905477T4 (tr) 2011-01-24 2019-05-21 Anterios Inc Nano-parçacık bileşimler.
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
CN107184980A (zh) * 2011-03-03 2017-09-22 南希·约瑟芬·波利克 顺势疗法的治疗方法及其组合物
DK2683385T3 (en) 2011-03-10 2018-09-17 Rigel Pharmaceuticals Inc 2,4-SUBSTITUTED PYRIMIDINE DIAMINES FOR DISKOID LUPUS USE
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
BE1020027A3 (fr) 2011-06-23 2013-04-02 Jean Pierre Mageren Compositions homeopathiques pour le traitement des douleurs du dos et des sciatiques.
EP2841098A4 (de) 2012-04-23 2016-03-02 Allertein Therapeutics Llc Nanopartikel zur behandlung von allergien
KR101365321B1 (ko) * 2012-05-22 2014-02-20 제일약품주식회사 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제
EP2895172B1 (de) 2012-09-12 2019-02-06 Rigel Pharmaceuticals, Inc. Vitiligo-behandlung
JP2016516754A (ja) 2013-04-03 2016-06-09 アラーテイン・セラピューティクス・リミテッド・ライアビリティ・カンパニーＡｌｌｅｒｔｅｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， ＬＬＣ 新規のナノ粒子組成物
AU2015252949B2 (en) 2014-05-01 2020-12-10 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
JP2018521089A (ja) 2015-07-24 2018-08-02 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 白斑の治療
KR102487144B1 (ko) 2016-11-21 2023-01-12 에이리온 테라퓨틱스, 인코포레이티드 큰 물질의 경피 전달
US11149262B2 (en) 2017-12-20 2021-10-19 Alleergan, Inc. Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation
AU2019339488B2 (en) 2018-09-13 2025-07-10 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (PAI-1) inhibitors
JP2021535925A (ja) 2018-09-13 2021-12-23 エイリオン セラピューティクス， インコーポレイテッド プラスミノーゲンアクチベーターインヒビター１（ｐｌａｓｍｉｎｏｇｅｎ ａｃｔｉｖａｔｏｒ ｉｎｈｉｂｉｔｏｒ １）（ＰＡＩ−１）阻害剤（ｉｎｈｉｂｉｔｏｒ）およびその使用
WO2020117564A1 (en) 2018-12-03 2020-06-11 Eirion Therapeutics, Inc. Improved delivery of large agents
CA3139983A1 (en) 2019-05-14 2020-11-19 Eirion Therapeutics, Inc. Delaying peak effect and/or extending duration of response
WO2021003315A1 (en) 2019-07-02 2021-01-07 Rowley Clifford T Transdermal patch providing improved permeability
US20230125585A1 (en) 2019-08-02 2023-04-27 Enterin, Inc. Dosing protocols and regimens for aminosterol treatment
WO2025064449A1 (en) 2023-09-18 2025-03-27 Eirion Therapeutics, Inc. Topical compositions and uses of pai-1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
WO1992006701A1 (en) * 1990-10-18 1992-04-30 Huffstutler, M., Conrad, Jr. Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use

Also Published As

Publication number Publication date
KR950007808A (ko) 1995-04-15
DE69414502T2 (de) 1999-04-08
DK0641561T3 (da) 1999-07-26
EP0641561B1 (de) 1998-11-11
JPH07165566A (ja) 1995-06-27
ITRM930591A1 (it) 1995-03-02
DE69414502D1 (de) 1998-12-17
IT1261849B (it) 1996-06-03
EP0641561A2 (de) 1995-03-08
EP0641561A3 (de) 1995-09-27
CA2129760A1 (en) 1995-03-03
ITRM930591A0 (it) 1993-09-02
ZA946698B (en) 1995-05-02
GR3029308T3 (en) 1999-05-28
US5683712A (en) 1997-11-04
ES2125380T3 (es) 1999-03-01

Similar Documents

Publication Publication Date Title
ATE173162T1 (de) Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
KR900701274A (ko) 남용 가능성을 감소시킨 용량 제형
DE3881340D1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
ES2060593T3 (es) Sistema de aporte de farmacos.
ATE219666T1 (de) Pflaster zur transdermalen verabreichung eines medikaments
DK0831827T3 (da) Nye formuleringer til transdermal levering af pergolid
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
DE3778223D1 (de) Biologisch erodierbares system mit gesteuerter freisetzung des arzneiwirkstoffes.
ATE161735T1 (de) Pharmazeutisches mittel zur behandlung von mit herpes-zoster assoziierten schmerzen und von postherpetischen neuralgien mittels lokaler anwendung von lokalanästhetika
KR900015761A (ko) 경피성 단일체 시스템
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
DK183389D0 (da) Fremgangsmaade til fremstilling af en administrerings- og/eller doseringsform for medicinsk aktive materialer
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
AU6229086A (en) Novel transdermal anti-anginal pharmaceutical dosage unit and process for its administration
DE59603246D1 (de) Flächenstabilisierte pharmazeutische zubereitung zur anwendung auf der haut

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee